Armata Pharmaceuticals Statistics

Total Valuation

ARMP has a market cap or net worth of $70.56 million. The enterprise value is $193.74 million.

Market Cap	70.56M
Enterprise Value	193.74M

Important Dates

The last earnings date was Wednesday, November 13, 2024, after market close.

Earnings Date	Nov 13, 2024
Ex-Dividend Date	n/a

Share Statistics

ARMP has 36.18 million shares outstanding. The number of shares has increased by 0.21% in one year.

Current Share Class	36.18M
Shares Outstanding	36.18M
Shares Change (YoY)	+0.21%
Shares Change (QoQ)	-37.88%
Owned by Insiders (%)	0.20%
Owned by Institutions (%)	3.83%
Float	11.04M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	12.89
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	35.44
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.19

Current Ratio	0.19
Quick Ratio	0.16
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-4.65

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-24.57%
Return on Capital (ROIC)	-27.20%
Revenue Per Employee	$82,833
Profits Per Employee	-$626,712
Employee Count	66
Asset Turnover	0.05
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -18.80% in the last 52 weeks. The beta is 0.82, so ARMP's price volatility has been lower than the market average.

Beta (5Y)	0.82
52-Week Price Change	-18.80%
50-Day Moving Average	2.27
200-Day Moving Average	2.66
Relative Strength Index (RSI)	37.05
Average Volume (20 Days)	9,751

Short Selling Information

The latest short interest is 4,540, so 0.01% of the outstanding shares have been sold short.

Short Interest	4,540
Short Previous Month	3,372
Short % of Shares Out	0.01%
Short % of Float	0.04%
Short Ratio (days to cover)	0.86

Income Statement

In the last 12 months, ARMP had revenue of $5.47 million and -$41.36 million in losses. Loss per share was -$1.14.

Revenue	5.47M
Gross Profit	-28.05M
Operating Income	-41.48M
Pretax Income	-79.58M
Net Income	-41.36M
EBITDA	-40.24M
EBIT	-41.48M
Loss Per Share	-$1.14

Full Income Statement

Balance Sheet

The company has $17.14 million in cash and $140.33 million in debt, giving a net cash position of -$123.19 million or -$3.40 per share.

Cash & Cash Equivalents	17.14M
Total Debt	140.33M
Net Cash	-123.19M
Net Cash Per Share	-$3.40
Equity (Book Value)	-50.97M
Book Value Per Share	-1.41
Working Capital	-95.82M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$37.73 million and capital expenditures -$4.36 million, giving a free cash flow of -$42.09 million.

Operating Cash Flow	-37.73M
Capital Expenditures	-4.36M
Free Cash Flow	-42.09M
FCF Per Share	-$1.16

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-758.66%
Pretax Margin	-756.59%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ARMP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.21%
Shareholder Yield	-0.21%
Earnings Yield	-58.62%
FCF Yield	-59.65%

Analyst Forecast

The average price target for ARMP is $7.00, which is 268.42% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$7.00
Price Target Difference	268.42%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ARMP has an Altman Z-Score of -6.8 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.8
Piotroski F-Score	2